Tür Tanımlamada Yeni Yöntemler

Authors

Taylan Bozok
https://orcid.org/0000-0002-7094-4838

References

Guiraud J, Piau C, Enault C, et al. Comparison of the molecular FluoroType Mycobacteria VER 1.0 and the Maldi BioTyper Mycobacteria assays for the identification of non-tuberculous mycobacteria. Journal of Clinical Microbiology. 2025;63(1):e01206-24. doi:10.1128/jcm.01206-24

Wengenack NL, Brown-Elliott BA, Parrish NM, et al. This is giving me a complex: A practical attempt to streamline nontuberculous mycobacteria nomenclature for clinical purposes. Journal of Clinical Microbiology. 2024;62(3):e01531-23. doi:10.1128/jcm.01531-23

European Centre for Disease Prevention and Control (ECDC). Handbook on Tuberculosis Laboratory Diagnostic Methods in the European Union: Updated 2026. Stockholm: ECDC; 2026. doi:10.2900/8334202

Wang X, Zhao L, Zhao H, et al. Diagnostic performance of MALDI-TOF MS for non-tuberculous mycobacteria: A systematic review and meta-analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(2):315–329. doi:10.1007/s10096-025-05308-0

Chen X, Sun J, Chen X, et al. Comparative evaluation of molecular technologies for the identification of prevalent non-tuberculous mycobacteria in pulmonary infections: A systematic review and meta-analysis. Annals of Medicine. 2026;58(1):2626123. doi:10.1080/07853890.2026.2626123

Richter E, Rüsch-Gerdes S, Hillemann D. Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. Journal of Clinical Microbiology. 2006;44(5):1769–1775. doi:10.1128/JCM.44.5.1769-1775.2006

Mougari F, Loiseau J, Veziris N, et al. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. Journal of Antimicrobial Chemotherapy. 2017;72(6):1669–1677.

Tortoli E, Mariottini A, Mazzarelli G. Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved reverse hybridization multiple DNA probe assay for mycobacterial identification. Journal of Clinical Microbiology. 2003;41(9):4418–4420.

Compiro P, Chomta N, Nimnual J, et al. CRISPR-Cas12a-based detection and differentiation of Mycobacterium spp. Clinica Chimica Acta. 2025;567:120101.

Zou Y, Wang Z, Wei Z, et al. Rapid identification of major Mycobacterium species by loop-mediated isothermal amplification assay using novel species-specific genomic targets. Frontiers in Cellular and Infection Microbiology. 2025;15:1653602.

Issa R, Abdul H, Hashim SH, et al. High resolution melting analysis for the differentiation of Mycobacterium species. Journal of Medical Microbiology. 2014;63(10):1284–1287

Khosravi AD, Meghdadi H, Hashemzadeh M, et al. Application of a new designed high resolution melting analysis for mycobacterial species identification. BMC Microbiology. 2024;24(1):205.

Chen JH, Cheng VC, She KK, et al. Application of a dual target PCR-high resolution melting (HRM) method for rapid nontuberculous mycobacteria identification. Journal of Microbiological Methods. 2017;132:1–3.

Yadav RN, Chowdary YY, Bhalla M, et al. Identification of nontuberculous Mycobacterium species by polymerase chain reaction-restriction enzyme analysis (PCR-REA) of rpoB gene in clinical isolates. International Journal of Mycobacteriology. 2024;13(3):307–313.

Kim BJ, Lee KH, Park BN, et al. Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB). Journal of Clinical Microbiology. 2001;39(6):2102–2109.

Yu Q, Wang Y, Gao Z, et al. DNA microarray chip assay in new use: Early diagnostic value in cutaneous mycobacterial infection. Frontiers in Cellular and Infection Microbiology. 2023;13:1183078.

Xiang B, Zeng W, Wu M, et al. Diagnostic accuracy and clinical impact of DNA microarray chip in pulmonary mycobacterial infections: A retrospective cohort study. BMC Infectious Diseases. 2026;26(1):205. doi:10.1186/s12879-025-12402-3

Fang H, Shangguan Y, Wang H, et al. Multicenter evaluation of the biochip assay for rapid detection of mycobacterial isolates in smear-positive specimens. International Journal of Infectious Diseases. 2019;81:46–51.

Zhu Y, Liu Z, Peng L, et al. Evaluation of nucleotide MALDI-TOF-MS for the identification of Mycobacterium species. Frontiers in Cellular and Infection Microbiology. 2024;14:1335104. doi:10.3389/fcimb.2024.1335104

Yao L, Gui X, Wu X, et al. Rapid identification of nontuberculous mycobacterium species from respiratory specimens using nucleotide MALDI-TOF MS. Microorganisms. 2023;11(8):1975.

Maciejak-Jastrzębska A, Sygitowicz G, Brzezińska S, et al. Tuberculosis today: Microbial insights, epidemiological trends, and the role of molecular diagnostics. Pathogens. 2025;14(10):965. doi:10.3390/pathogens14100965

Zhang H, Tang M, Li D, et al. Applications and advances in molecular diagnostics: Revolutionizing non-tuberculous mycobacteria species and subspecies identification. Frontiers in Public Health. 2024;12:1410672. doi:10.3389/fpubh.2024.1410672

Szewczyk R, Druszczynska M, Majewski K, et al. Detection and accurate identification of Mycobacterium species by flow injection tandem mass spectrometry (FIA-MS/MS) analysis of mycolic acids. Scientific Reports. 2025;15(1):13118. doi:10.1038/s41598-025-96867-x

Trinh MP, Shin MK. Challenges and advances in mycobacterial molecular typing. Annals of Clinical Microbiology. 2025;28(3):18.

Byrne AS, Goudreau A, Bissonnette N, et al. Methods for detecting mycobacterial mixed strain infections: A systematic review. Frontiers in Genetics. 2020;11:600692. doi:10.3389/fgene.2020.600692

Meghdadi H, Khosravi AD, Hashemzadeh M, et al. New design of multilocus sequence analysis of rpoB, ssrA, tuf, atpE, ku, and dnaK for identification of Mycobacterium species. Molecular Biology Reports. 2022;49(8):7967–7977. doi:10.1007/s11033-022-07638-0

Wang S, Xing L. Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections. Frontiers in Cellular and Infection Microbiology. 2023;13:1253020.

Dohál M, Wetzstein N, Hromádková M, et al. Diagnostics, resistance and clinical relevance of non-tuberculous mycobacteria unidentified at the species level by line probe assays: A bi-national study. Annals of Clinical Microbiology and Antimicrobials. 2025;24(1):14.

Notarte KI, Allen K, Armstrong DT, et al. Evaluation of the Deeplex Myc-TB-targeted next-generation sequencing assay for mycobacterial identification and drug resistance detection. Journal of Clinical Microbiology. 2026;64(7):e00082-26. doi:10.1128/jcm.00082-26

Jouet A, Gaudin C, Badalato N, et al. Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs. European Respiratory Journal. 2021;57(3):2002338. doi:10.1183/13993003.02338-2020

Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: A retrospective cohort study. The Lancet. 2013;381(9877):1551–1560.

van Ingen J, Kohl TA, Kranzer K, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: A molecular epidemiological study. The Lancet Infectious Diseases. 2017;17(10):1033–1041.

Ghayas H, Ashraf J, Saeed N, et al. Identification and drug resistance profiling of Mycobacterium orygis from an African elephant using whole-genome sequencing. Microbiology Spectrum. 2026;14(6):e03586-25.

Walker TM, Ip CL, Harrell RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: A retrospective observational study. The Lancet Infectious Diseases. 2013;13(2):137–146.

Roetzer A, Diel R, Kohl TA, et al. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: A longitudinal molecular epidemiological study. PLoS Medicine. 2013;10(2):e1001387.

Published

November 17, 2026

License

License